Equities

Avacta Group PLC

AVCT:LSE

Avacta Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)60.50
  • Today's Change0.50 / 0.83%
  • Shares traded742.88k
  • 1 Year change28.72%
  • Beta1.3712
Data delayed at least 20 minutes, as of Feb 06 2026 17:09 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Avacta Group PLC's revenues fell -96.04% from 2.85m to 113.00k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 33.26m to a larger loss of 52.84m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-55.83%
Return on equity-138.13%
Return on investment-129.38%
More ▼

Cash flow in GBPView more

In 2024, Avacta Group PLC increased its cash reserves by 6.92%, or 1.15m. Cash Flow from Financing totalled 26.10m or 23,092.92% of revenues. In addition the company used 23.60m for operations while cash used for investing totalled 1.43m.
Cash flow per share-0.0868
Price/Cash flow per share--
Book value per share0.0004
Tangible book value per share-0.0043
More ▼

Balance sheet in GBPView more

Avacta Group PLC has a Debt to Total Capital ratio of 99.30%, a higher figure than the previous year's 4.12%.
Current ratio0.7883
Quick ratio0.7883
Total debt/total equity141.69
Total debt/total capital0.993
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.